BiTrial CRO | Hungary

Hungary, located in the heart of Central Europe, is a country where history meets natural beauty. As an EU member, Hungary has made significant advancements in technology and infrastructure, becoming a key player in the region.

European Union (EU) member since: 2004

Total Population: 9.585.818* (2026)

BiTrial in Hungary
Conducting clinical trials in Hungary is advantageous due to several key factors. The country boasts a well-established healthcare system with highly skilled medical professionals, ensuring high-quality data collection and patient care. Hungary’s regulatory framework is aligned with EU standards, providing a robust and efficient approval process for clinical studies. Additionally, the diverse patient population and high enrollment rates contribute to faster recruitment, while lower operational costs compared to Western Europe make it a cost-effective location for conducting trials.
🏥 Is Hungary a good country for clinical research?

Lower study costs combined with high patient participation willingness.

Centralized healthcare system enabling rapid and efficient patient recruitment.

Strong recruitment potential across a wide range of indications, ideal for multi-country trials.

Highly educated and skilled medical professionals trained across diverse therapeutic areas.

All investigators hold up-to-date GCP certifications, renewed every 5 years.

Excellent research infrastructure supported by a modern hospital network.

Developed transport system ensuring smooth and reliable logistics nationwide.